Before, During and After the Sale Process
Presented By: Dickinson Wright / Aon
A panel of entrepreneurs and experts share front-line stories of how they have positioned their companies — and their clients’ — for sale. They will also provide you with a glimpse of what life for an owner looks like after the deal closes.
Dickinson Wright PLLC
Ben is a corporate transactional attorney who has represented a wide range of public and private companies and many of the leading international private equity sponsors. He has significant experience advising clients on domestic and cross-border M&A, leveraged buyouts, joint ventures, minority investments, divestitures and restructurings. Ben also is an adjunct professor at The Ohio State University Moritz College of Law and serves on the board of NoticeAbility and the advisory board of Calmer Choice.
Vipul is a senior vice president at Aon Risk Solutions and a senior broker in Aon’s Transaction Solutions Practice. He brokers, structures and negotiates representations and warranties insurance policies in connection with mergers and acquisitions by private equity firms and corporations with a focus on healthcare provider transactions. Previously, he was a vice president in the health care investment banking group at Robert W. Baird, where he focused on mergers, acquisitions and capital raising transactions.
EVP, COO & CFO
Jeni's Splendid Ice Creams
Poe is a forward-thinking, trusted financial expert with unique and diverse experience in publicly-traded, private-equity owned, and closely-held companies. She has over 30 years of experience at the executive level helping companies achieve their strategic objectives, drive enterprise wide growth, efficiency, and improved profit margins, as well as support talent development initiatives. Poe currently serves as Executive Vice President, Chief Operating Officer and Chief Financial Officer of Jeni’s Splendid Ice Creams, an omni-channel super premium ice cream company with retail locations in nine states and products sold online and in specialty and conventional grocery stores across the United States.
President, Carmen Partners, LLC
Dr. Triplett is president of Carmen Partners LLC. He was previously co-founder, president and CEO of Myonexus Therapeutics, a gene therapy research company focused on development of five pre-clinical and clinical stage candidates for Limb-girdle Muscular Dystrophy. Myonexus was sold to Sarepta Therapeutics in April 2019 for $165 million.